Airborne Pathogen Simulants and Mobility Testing
Airborne pathogen mobility and the airborne mobility of respiratory droplets, such as saliva, and testing thereof, can be monitored by tracking detectable compounds and measuring concentrations. A display can be presented including a building layout and simulant concentrations released and collected at various locations within a space.
1 .- 14 . (canceled)
15 . A method of detecting a pathogen simulant, comprising:
determining a plurality of locations to receive a saliva simulant released in air, wherein the saliva simulant comprises water, a DNA taggant, and a carrier, the saliva simulant having been determined or characterized to have a behavior suitable for simulating human emission of a target pathogen;
collecting a sample at each location of the plurality of locations; and
determining an amount of the saliva simulant in the sample.
16 . The method of claim 15 , wherein the pathogen is SARS-Cov-2.
17 . The method of claim 15 , wherein the carrier comprises polysaccharides, proteins, salt, or a combination thereof.
18 . The method of claim 17 , wherein the polysaccharides comprise one or more of maltodextrin, cationic polysaccharides, and DEAE-Dextran.
19 . The method of claim 17 , wherein the proteins are single strand DNA binding proteins EcoSSB.
20 . The method of claim 15 , wherein the saliva simulant comprises dispensed liquid particles that transport through air sized from about 0.01 μm to about 100 μm, formed by binding the DNA taggant to a carrier polysaccharide and/or one or more proteins.
21 . The method of claim 15 , further comprising one or more additional carriers to form a saliva simulant solution containing around 99% H 2 O, and around 1% of a mixture of the polysaccharides, the proteins, the salt, or the combination thereof, and DNA taggants.
22 . The method of claim 21 , wherein the one or more additional carriers form a saliva simulant solution containing around 99% H 2 O, and around 1% of a mixture of the polysaccharides, the proteins, the salt, or the combination thereof, and the DNA taggants.
23 . The method of claim 15 , wherein the human emission is one or more of a human aerosol emission, a human droplet emission, a human droplet emission followed by at least partial evaporation to become aerosolized, and/or a combination thereof.
24 . The method of claim 15 , further comprising detecting and quantifying DNA taggants using PCR.
25 . The method of claim 15 , wherein the sample is an air sample, and wherein the collecting is performed by a vacuum apparatus having a vacuum flow rate that matches human breathing to collect the air sample.
26 . The method of claim 25 , wherein the vacuum apparatus is configured to have a pore size suitable for filtering the saliva simulant from the air sample.
27 . The method of claim 15 , wherein the behavior of the saliva simulant is suitable for simulating human coughing, sneezing, talking, yelling, and/or singing.
28 . The method of claim 15 , wherein the saliva simulant is constructed to have an evaporation rate similar to that of saliva.
29 . The method of claim 15 , further comprising:
recording humidity and temperature at each location of the plurality of locations; and
adjusting the determined amount of the saliva simulant in the sample according to the recorded humidity and temperature.